Biotech

All Articles

Otsuka spends $800M for Jnana as well as its clinical-stage PKU drug

.Otsuka Drug has grabbed Boston-based Jnana Therapeutics for $800 million so the Japanese biotech ma...

FibroGen gives up 75% of US workers as asset fails 2 even more trials

.FibroGen is actually radically reorganizing its company, laying off 75% of its USA workers and also...

Tracon relax weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has decided to wind down functions weeks after an injectable immune system g...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...

Takeda takes $140M reduction on stopped working epilepsy medicine, touts FDA run

.We presently know that Takeda is actually wanting to discover a pathway to the FDA for epilepsy med...

VBI Vaccines files for insolvency, finds property sale

.Immunology biotech VBI Vaccinations is diverting precariously near the moment of truth, with progra...

Celldex anti-cKIT antitoxin lessen colonies in another phase 2 research study

.It is actually not easy to muscular tissue in on a room as reasonable as immunology, however Cellde...

Boehringer provides to $1.3 B for gate inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Rehabs and also a preclinical immune sy...

Ventyx's last resort for inflammatory med ends in Crohn's failure

.Ventyx Biosciences' Crohn's illness medication carried out not help people obtain remission in a pe...

Cognition's period 2 sparkle records blemish Alzheimer's possibility

.Knowledge Therapies' stage 2 SHINE trial has taken a few of the appeal off the Alzheimer's disease ...